Cytosorbents (CTSO) Non-cash Items (2019 - 2026)

Cytosorbents has reported Non-cash Items for 8 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items fell 38.24% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 38.24% YoY), and the FY2025 full-year result was $1.5 million, down 50.0% from the prior year.
• Non-cash Items for Q1 2026 stood at $1.4 million, down from $1.5 million in the prior quarter.
• The five-year high for Non-cash Items was $8.0 million in Q3 2023, with the low at $4.0 in Q3 2025.
• Historically, Non-cash Items has averaged $3.5 million across 5 years, with a median of $3.8 million in 2023.
• Annual changes were most pronounced in 2023 — Non-cash Items soared 46.04% — and 2025, when it slumped 100.0%.
• Cytosorbents' Non-cash Items stood at $3.9 million in 2022, then rose by 25.37% to $4.9 million in 2023, then tumbled by 38.37% to $3.0 million in 2024, then slumped by 50.0% to $1.5 million in 2025, then slipped by 6.67% to $1.4 million in 2026.
• The last three Non-cash Items figures came in at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $4.0 (Q3 2025), per Business Quant data.